Education
About Us
Working with TipRanks
Follow Us
GENW - ETF AI Analysis
Top Page
Genter Capital International Dividend ETF (GENW)
Rating:70Outperform
Price Target:―
Positive Factors
Recent Performance Momentum
The ETF has shown positive returns over the past month, three months, and year-to-date, indicating improving recent performance.
Strong Financials Exposure
A large portion of the fund is invested in financial companies, several of which have delivered solid gains and supported overall returns.
Broad Sector Mix
Holdings spread across financials, industrials, consumer defensive, health care, energy, and other sectors help reduce reliance on any single industry.
Negative Factors
High Financial Sector Concentration
With a heavy tilt toward financial stocks, the fund is more exposed to downturns or stress in the banking and financial services industry.
Mixed Top-Holding Performance
A few of the largest positions, such as AstraZeneca and Enbridge, have shown weaker recent performance, which can drag on the fund’s overall results.
Small Asset Base
The ETF manages a relatively low level of assets, which can sometimes lead to lower trading liquidity and wider bid-ask spreads for investors.
GENW vs. SPDR S&P 500 ETF (SPY)
AUM4.03M
RegionGlobal
Expense Ratio0.38%
Beta0.51
IssuerGenter Capital
Inception DateJan 06, 2025
Dividend Yield2.59%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,524
30 Day Avg. Volume2,227
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GENW Summary
GENW is the Genter Capital International Dividend ETF, focused on high-dividend stocks from around the world, mainly outside the U.S. It does not track a set index, but instead picks international companies known for paying strong, steady dividends across many sectors like financials, utilities, and energy. Well-known holdings include AstraZeneca and Vodafone. Someone might invest in GENW to seek regular income and diversify beyond U.S. stocks. A key risk is that international dividend stocks can go up and down with global markets and may be affected by foreign economic and currency changes.
How much will it cost me?The Genter Capital International Dividend ETF (GENW) has an expense ratio of 0.38%, meaning you’ll pay $3.80 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed, focusing on selecting high-dividend international stocks to maximize returns for investors.
What would affect this ETF?GENW's focus on high-dividend international stocks could benefit from stable or growing global economic conditions, especially in sectors like Financials and Industrials, which make up a significant portion of its holdings. However, rising interest rates or economic slowdowns in key regions could negatively impact dividend-paying companies, particularly in sectors like Consumer Defensive and Energy. Regulatory changes or geopolitical tensions in countries where top holdings like Mitsubishi UFJ and Barclays operate could also influence the ETF's performance.
GENW Top 10 Holdings
GENW is being steered mainly by big global banks, with Japanese lenders Mitsubishi UFJ and Sumitomo Mitsui, along with Barclays, BBVA, and BNP Paribas, acting as the fund’s main engines and recently rising, thanks to solid financial results and upbeat sentiment. Outside of finance, ABB has been a steady industrial contributor, while utilities name Enel and telecom giant Vodafone add a more defensive, income-focused flavor. On the weaker side, AstraZeneca and Enbridge have been losing a bit of steam. Overall, it’s a globally diversified, dividend-heavy fund with a clear tilt toward international financials.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Sumitomo Mitsui | 5.02% | $203.00K | $141.87B | 46.06% | 76 Outperform | |
| Barclays | 4.95% | $200.18K | $88.20B | 71.89% | 77 Outperform | |
| Mitsubishi UFJ | 4.89% | $197.52K | $207.53B | 46.99% | 77 Outperform | |
| ABB Ltd | 4.19% | $169.40K | $164.56B | 59.01% | 77 Outperform | |
| Banco Bilbao | 3.86% | $156.09K | $131.23B | 85.84% | 76 Outperform | |
| AstraZeneca | 3.43% | $138.75K | $324.77B | 32.79% | 80 Outperform | |
| BNP Paribas | 3.40% | $137.30K | $120.34B | 52.04% | 72 Outperform | |
| Vodafone | 3.38% | $136.59K | $36.27B | 89.36% | 58 Neutral | |
| Telefonaktiebolaget LM Ericsson | 3.35% | $135.43K | $36.87B | 41.93% | 74 Outperform | |
| Orange SA | 3.25% | $131.38K | $53.78B | 75.47% | 63 Neutral |
GENW Technical Analysis
Positive
―
Price Trends
13.87
Positive
13.21
Positive
12.52
Positive
Market Momentum
0.35
Negative
70.14
Negative
83.13
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GENW, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 14.53, equal to the 50-day MA of 13.87, and equal to the 200-day MA of 12.52, indicating a bullish trend. The MACD of 0.35 indicates Negative momentum. The RSI at 70.14 is Negative, neither overbought nor oversold. The STOCH value of 83.13 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GENW.
GENW Peer Comparison
Comparison Results
Performance Comparison
GENW
Genter Capital International Dividend ETF
14.97
4.64
44.92%
FDIV
MarketDesk Focused U.S. Dividend ETF
―
―
―
DIVY
Sound Equity Income ETF
―
―
―
PAYR
Federated Hermes Enhanced Income ETF
―
―
―
DIVD
Altrius Global Dividend ETF Altrius Global Divid ETF
―
―
―
DVGR
DAC 3D Dividend Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents